Covid Is Over. It's Marburg Season.
And Bundibugyo virus, Ebola virus, Sudan virus, Taï Forest virus, Ebolaviruses Season.
Okie dokie…here we go. Again.
First, are you aware that we have been under a PREP Act Declaration for Marburg Virus since November of 2020? Yep.
The November 25, 2020, Declaration under the PREP Act for Countermeasures Against Marburgvirus and/or Marburg Disease was published on December 9, 2020.
→ If you are curious about what a PREP Act Declaration means, please see this post or this post.
And now we are amending it.
We…😂, just kidding…WE aren’t doing anything. One dude is. The Secretary of Health and Human Services gets to decide this. By himself. His name is Xavier Becerra, and make no mistake, he is in control.
He decided we need to expand it…it’s like a Three-fer. THREE THINGS A ONCE. Two things at once is sooooo last year.
This action has the effect of combining the three previous Declarations into one amended Declaration and makes PREP Act coverage for Ebolavirus countermeasures consistent with PREP Act coverage provided for other health threats, including Marburg, Smallpox, Pandemic Influenza, Anthrax, and Acute Radiation Syndrome and emerging infectious diseases such as COVID–19.
So put your detective hat on, because I think we can probably figure out how this is going to go down.
First of all….I’d like to highlight that NOTHING HAS CHANGED, despite the Covid plan to murder the world not “pandemic” being not over (PREP Act declaration for Covid goes until December of 2024, btw).
Exactly ZERO laws have been changed and the PREP Act hasn’t been repealed. So literally EVERYTHING that went down with Covid, can happen again.
By the way, this might be of interest, did you know that all 50 states have rules in place for Quarantine Camps? Well they do.
Ok friends, let’s look at this PREP Act declaration BULLSHIT. I have copied and pasted all relevant excerpts below, directly from the The Federal Register. Please do peruse it in its entirety for yourself.
SUMMARY:
The Secretary issues this amendment pursuant to section 319F–3 of the Public Health Service Act to amend the Declaration for Countermeasures against Marburgvirus and/or Marburg Disease to cover both Ebolaviruses and Marburgviruses and republishes the declaration, as amended. The amended republished Declaration clarifies that the disease threat includes Ebolaviruses and Marburgviruses, updates the title of the Declaration, expands the Covered Countermeasures, and extends the effective time period.
DATES:
The amendment is effective as of January 1, 2024.
Alright, so we are expanding the Covered Countermeasures and extending them. Phew.
SUPPLEMENTARY INFORMATION:
The Public Readiness and Emergency Preparedness Act (PREP Act) authorizes the Secretary of the U.S. Department of Health and Human Services (the HHS Secretary) to issue a Declaration to provide liability immunity to certain individuals and entities (Covered Persons) against any claim of loss caused by, arising out of, relating to, or resulting from the manufacture, distribution, administration, or use of medical countermeasures (Covered Countermeasures), except for claims involving “willful misconduct” as defined in the PREP Act. Under the PREP Act, a Declaration may be amended as circumstances warrant.
To be clear…
→The purpose of issuing a PREP Act declaration (Public Health Emergency) is SPECIFICALLY to provide immunity from liability for claims relating to countermeasures.
FYI, after a PREP Act declaration…
→The Secretary of HHS may then declare that Emergency Use Authorization (EUA) is appropriate. Under EUA, the FDA may then authorize unapproved medical products or unapproved uses of approved medical products, as we saw in the previous section.
I am extending PREP Act Coverage for both Ebolaviruses and Marburgviruses due to the continued national security threat posed by these viruses. Ebolaviruses and Marburgviruses have the potential to cause significant morbidity and mortality during outbreaks. The risk of domestic cases is high due to ongoing outbreaks in other countries over the past decade. Development of and stockpiling vaccines, therapeutics, devices, and diagnostics for all species of both Ebolaviruses and Marburgviruses is needed for continued U.S. preparedness against the credible threat of a public health emergency due to outbreaks of these viruses.
I am amending the PREP Act Declaration for Countermeasures Against Marburgvirus and/or Marburg Disease to cover countermeasures previously covered under the Declaration for Ebola Virus Disease Vaccines and the Declaration for Ebola Virus Disease Therapeutics due to the similarities of the viruses and the need to expand Covered Countermeasures against Ebola Disease to include all vaccines, diagnostics, and devices in addition to previously covered vaccines and therapeutics, and to cover these countermeasures when administered or used by an Authority Having Jurisdiction to respond to a declared emergency, in addition to previously covered activities directly supported by the United States. All previously Covered Countermeasures for Ebolavirus and distribution activities continue to be covered. This action has the effect of combining the three previous Declarations into one amended Declaration and makes PREP Act coverage for Ebolavirus countermeasures consistent with PREP Act coverage provided for other health threats, including Marburg, Smallpox, Pandemic Influenza, Anthrax, and Acute Radiation Syndrome and emerging infectious diseases such as COVID–19.[] This amended Declaration for Countermeasures Against Ebolavirus and/or Ebola Disease and Marburgvirus and/or Marburg Disease supersedes the PREP Act Declaration for Ebola Virus Disease Vaccines and the PREP Act Declaration for Ebola Virus Disease Therapeutics. The Declarations for Ebola Virus Disease Vaccines and Ebola Virus Disease Therapeutics will expire under their own terms on December 31, 2023 and this amended Declaration becomes effective January 1, 2024, effectively replacing the three prior Declarations.
To be consistent with the most current World Health Organization International Classification of Diseases, the term Ebola disease or “EBOD” is used in this Declaration to refer to the disease, health condition, or threat to health that constitutes or may constitute a public health emergency. The term Marburg Disease or “MARD” is used in this Declaration to refer to the disease, health condition, or threat to health that constitutes or may constitute a public health emergency.[]
Did you catch the language there?
“…threat to health that constitutes or MAY CONSTITUTE a public health emergency."
So this meeebeee might be an emergency.
Good enough!!
Full steam ahead, guys.
Specifically, I am now amending the PREP Act Declaration Against Marburgvirus and/or Marburg Disease Countermeasures to: amend the title of the declaration to reflect that it covers Ebolaviruses and Marburgviruses; update Section I to identify the public health threat as arising from Ebolaviruses and Marburgviruses; update Section VI to amend the definition of Covered Countermeasures and to extend coverage to all vaccines, diagnostics, and devices for Ebolavirus in addition to vaccines and therapeutics; extend Section VII of the Declaration to provide coverage for Ebolavirus Countermeasures when administered or used by an Authority Having Jurisdiction to respond to a declared emergency; update Section VIII to amend the category of disease to be inclusive of Ebolaviruses and Marburgviruses; extend in Section XII the effective time period of the declaration through December 31, 2028; and republish the declaration in its entirety, as amended.
Gosh, what do the Covered Countermeasures include? Let’s have a lil looksee…
Section VI. Covered Countermeasures
I am amending Section VI of the Declaration to include any antiviral, any other drug, any biologic, any diagnostic, any other device, or any vaccine, used to diagnose, mitigate, prevent, treat, cure, or limit EBOD, MARD, or the transmission of Ebolaviruses, Marburgviruses, or a virus mutating therefrom, or any device used in the administration of any such product, and all components and constituent materials of any such product.
Ok guys….keep your detective hats on. The Covered Countermeasures cover everything (including the diagnostic tools).
Hey do you think that they’ll use the PCR look for a “signal” test to “diagnose” these Big Scary Viruses?
🤔 Funnily enough, I already have a post started about this PCR hemorrhagic fever piece, but the EbolaBurg Rollout was faster than me.
→ Pssst….it might be moving at the Speed of Science ←
Spoiler Alert: Conspiracy Sarah thinks they’re going to use the AMAZING PCR signaling fuckery Test that can can test for anything and nothing all the time anywhere and nowhere.
Relevant:
Situational Update:
Uganda officially declared an EVD outbreak on September 20, 2022 and the causative agent is the Sudan ebolavirus. Since the outbreak onset, there have been cases reported and confirmed in various districts in Uganda. For further information, please see this statement from the World Health Organization.As of November 14, 2022, PHO’s laboratory will perform the Ebolavirus PCR assay to detect the Sudan ebolavirus species. PHO’s laboratory will provide a preliminary result for specimens received from patients with suspected Sudan ebolavirus infection; specimens will also be referred to the National Microbiology Laboratory (NML) in Winnipeg for parallel testing. Please refer to NML’s Guide to Services - Molecular Detection of Ebola virus for more information including turn around time. (source)
Gosh, I wonder what the CDC thinks about these Big Scary Viruses and how to diagnose them…
CDC
Clinical diagnosis of Marburg virus disease (MVD) can be difficult. Many of the signs and symptoms of MVD are similar to other infectious diseases (such as malaria, typhoid fever, or dengue) or viral hemorrhagic fevers that may be endemic in the area (such as Lassa fever or Ebola). This is especially true if only a single case is involved.
If a person has early symptoms of MVD and a possible exposure to marburgvirus, the patient should be isolated and public health professionals notified. Samples from the patient can then be collected and tested to confirm infection.
Antigen-capture enzyme-linked immunosorbent assay (ELISA) testing, polymerase chain reaction (PCR), and IgM-capture ELISA can be used to confirm a case of MVD within a few days of symptom onset. Virus isolation may also be performed but should only be done in a high containment laboratory with good laboratory practices. The IgG-capture ELISA is appropriate for testing persons later in the course of disease or after recovery. In deceased patients, immunohistochemistry, virus isolation, or PCR of blood or tissue specimens may be used to diagnose MVD retrospectively. (source)
Conspiracy Sarah also thinks we should be on the lookout for some WASTEWATER fuckery testing. Wastewater Testing is an EXCELLENT way to tell people they have something they can’t see and don’t have symptoms for “get ahead” of infections. I wrote about this special kind of fuckery here:
And here:
Ok, back to our amended PREP Act Declaration….
Section VIII. Category of Disease, Health Condition, or Threat
I am amending Section VIII of the Declaration to update the category of disease to include any diseases or conditions including EBOD and MARD caused by Ebolaviruses and Marburgviruses, or any virus or disease subcategories of these or virus mutating therefrom.
So it covers any potential variant too.
Cool. Because, variants make endless pandemics possible sure are scary.
Glad they got those pre-covered.
Section XII. Effective Time Period
I am extending the effective time period for the Declaration through December 31, 2028.
DECEMBER 31, 2028?!?!?!
🥳 Awesome!!
And here we are. Public Health Emergency.
I. Determination of Public Health Emergency
I have determined that there is a credible risk that the spread of Ebolaviruses and Marburgviruses, and any resulting diseases or conditions including Ebola Disease (EBOD) and Marburg Disease (MARD), and any virus or disease subcategories of these may in the future constitute a public health emergency. For the purposes of this Declaration, MARD is the illness resulting from infection by any virus of the Orthomarburgvirus genus. EBOD is the illness resulting from infection of any of the following virus species of the Orthoebolavirus genus:
Bundibugyo virus
Ebola virus
Sudan virus
Taï Forest virus
Ebolaviruses with undefined pathogenicity in humans
II. Factors Considered
I have considered the desirability of encouraging the design, development, clinical testing, or investigation, manufacture, labeling, distribution, formulation, packaging, marketing, promotion, sale, purchase, donation, dispensing, prescribing, administration, licensing, and use of the Covered Countermeasures.
👏🏼👏🏼 And away we goooooo!!!!
III. Recommended Activities
I recommend, under the conditions stated in this Declaration, the manufacture, testing, development, distribution, administration, and use of the Covered Countermeasures.
IV. Liability Immunity
42 U.S.C. 247d–6d(a), 247d–6d(b)(1)
Liability immunity as prescribed in the PREP Act and conditions stated in this Declaration is in effect for the Recommended Activities described in Section III.
V. Covered Persons
42 U.S.C. 247d–6d(i)(2), (3), (4), (6), (8)(A) and (B)
Covered Persons who are afforded liability immunity under this Declaration are “manufacturers,” “distributors,” “program planners,” “qualified persons,” and their officials, agents, and employees, as those terms are defined in the PREP Act, and the United States. In addition, I have determined that the following additional persons are qualified persons: (a) Any person authorized in accordance with the public health and medical emergency response of the Authority Having Jurisdiction, as described in Section VII below, to prescribe, administer, deliver, distribute or dispense the Covered Countermeasures, and their officials, agents, employees, contractors and volunteers, following a Declaration of an emergency; (b) any person authorized to prescribe, administer, or dispense the Covered Countermeasures or who is otherwise authorized to perform an activity under an Emergency Use Authorization in accordance with section 564 of the FD&C Act; and (c) any person authorized to prescribe, administer, or dispense Covered Countermeasures in accordance with section 564A of the FD&C Act.
Got that? Everyone involved is shielded from liability. Errrrryone.
VI. Covered Countermeasures
42 U.S.C. 247d–6b(c)(1)(B), 42 U.S.C. 247d–6d(i)(1) and (7)
Covered Countermeasures are: (1) any antiviral, any other drug, any biologic, any diagnostic, any other device, or any vaccine, used to diagnose, mitigate, prevent, treat, cure, or limit the harm EBOD, MARD, or the transmission of Ebolaviruses, Marburgviruses, or a virus mutating therefrom, any device used in the administration of any such product, and all components and constituent materials of any such product; (2) any product to diagnose, mitigate, prevent, treat, or cure a serious or life-threatening disease or condition caused by a product described in clause (1); or (3) a product or technology intended to enhance the use or effect of a drug, biological product, or device described in clause (1) or (2).
Covered Countermeasures must be “qualified pandemic or epidemic products,” or “security countermeasures,” or drugs, biological products, or devices authorized for investigational or emergency use, as those terms are defined in the PREP Act, the FD&C Act, and the Public Health Service Act.
Y’ALL. Read all of that again. Medications and vaccines, blah, blah, blah…but there’s that word TECHNOLOGY that sure seems to be sneaking into a lot of medical spaces. So all the drugs and anything associated with them, including technology (now apparently synonymous with medicine), is covered.
And then we are also covering any product to diagnose, mitigate, prevent, treat, or cure a serious or life-threatening disease or condition caused by a product described in clause (1) or (2).
So that’s some real pre-fuckery planning, if you ask me 😂.
If you almost get dead by one of our Beautiful Countermeasures and we have to diagnose, treat, or cure that lil oopsie…don’t worry, we’ve covered our asses there too…you can’t sue anyone for anything that happens. Ever.
Hey, did you love the part of the Covid Bullshit “pandemic” concerning Other Transaction Authorities? Well, get excited, because IT’S BAAAAACK 🤗!!!
VII. Limitations on Distribution
42 U.S.C. 247d}6d(a)(5) and (b)(2)(E)
I have determined that liability immunity is afforded to Covered Persons only for Recommended Activities involving Covered Countermeasures that are related to:
(a) Present or future federal contracts, cooperative agreements, grants, other transactions, interagency agreements, memoranda of understanding, or other federal agreements, or activities directly conducted by the Federal Government; or
(b) Activities authorized in accordance with the public health and medical response of the Authority Having Jurisdiction to prescribe, administer, deliver, distribute, or dispense the Covered Countermeasures following a Declaration of an emergency.
i. The Authority Having Jurisdiction means the public agency or its delegate that has legal responsibility and authority for responding to an incident, based on political or geographical ( e.g., city, county, tribal, state, or federal boundary lines) or functional ( e.g., law enforcement, public health) range or sphere of authority.
ii. A Declaration of emergency means any Declaration by any authorized local, regional, state, or federal official of an emergency specific to events that indicate an immediate need to administer and use the Covered Countermeasures, with the exception of a federal Declaration in support of an Emergency Use Authorization under section 564 of the FD&C Act unless such Declaration specifies otherwise.
I know, I know, you’re probably worried that maybe everyone isn’t completely protected from liability. I mean, is everyone really shielded????
Yes.
I have also determined that, for governmental program planners only, liability immunity is afforded only to the extent such program planners obtain Covered Countermeasures through voluntary means, such as (1) donation; (2) commercial sale; (3) deployment of Covered Countermeasures from federal stockpiles; or (4) deployment of donated, purchased, or otherwise voluntarily obtained Covered Countermeasures from state, local, or private stockpiles.
IX. Administration of Covered Countermeasures
X. Population
42 U.S.C. 247d–6d(a)(4), 247d–6d(b)(2)(C)
The populations of individuals include any individual who uses or is administered the Covered Countermeasures in accordance with this Declaration.
Liability immunity is afforded to manufacturers and distributors without regard to whether the countermeasure is used by or administered to this population; liability immunity is afforded to program planners and qualified persons when the countermeasure is used by or administered to this population, or the program planner or qualified person reasonably could have believed the recipient was in this population.
XI. Geographic Area
42 U.S.C. 247d–6d(a)(4), 247d–6d(b)(2)(D)
Liability immunity is afforded for the administration or use of a Covered Countermeasure without geographic limitation.
Liability immunity is afforded to manufacturers and distributors without regard to whether the countermeasure is used by or administered in any designated geographic area; liability immunity is afforded to program planners and qualified persons when the countermeasure is used by or administered in any designated geographic area, or the program planner or qualified person reasonably could have believed the recipient was in that geographic area.
Authority: 42 U.S.C. 247d–6d.
Dated: November 21, 2023.
Xavier Becerra,
Secretary, Department of Health and Human Services.
I guess that about wraps it up for the Sunday Evening Bullshit Update.
Which reminds me…Are you a Bullshit Whisper? Do you wish you had a shirt?
Well, I made one.
About this item
Is bullshit your other language? Be sure to let others know you're fluent.
Are you a bullshit whisperer? Able to tease out the truth? The world needs your superpower now.
Lightweight, Classic fit, Double-needle sleeve and bottom hem.